Kidney Health Coaching for Advanced Kidney Disease

This study, called "Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease," is testing if Kidney Health Coaching can help people with advanced kidney disease. You might be able to join if you identify as African American or Black, are 18 or older, and have specific kidney function test results (eGFR less than 29) or a high risk of kidney failure. The study aims to see if this coaching can delay the need for kidney replacement therapy (like dialysis) or a central venous catheter, and also delay death. The coaching involves support from a Kidney Health Coach, who has personal experience with kidney disease, through phone calls and in-person meetings for six months. The study compares this coaching to usual care, which might include support from care management at the hospital.

Study design
This is an interventional study with a planned enrollment of 600 participants. It uses a randomized controlled trial design, meaning participants will be randomly assigned to either receive Kidney Health Coaching or usual care.
What's involved
If you participate, you would receive ongoing telephone support at least twice a month for six months, and the Kidney Health Coach would meet you at all in-person clinic appointments. You would also complete a baseline assessment via telephone interview.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed throughout study participation up to 12 months to measure the time to kidney replacement therapy and death.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06693661

Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease

Recruiting
NAAges 18+InterventionalSupportive care
Emory University
~600 participants
Updated 2026-06-04 on ClinicalTrials.gov
What's tested:Kidney Health CoachingUsual Care

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time-to-Kidney Replacement Therapy w/Central Venous Catheter
Measured over Throughout study participation up to 12 months
+1 more outcome measured
Kidney Diseases

NCT06693661

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Emory Healthcare System

    Atlanta, Georgiano site contact published

    Recruiting

  • Emory University Hospital Midtown

    Atlanta, Georgiano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Kimberly R Jacob Arriola, PhD, MPH · PRINCIPAL_INVESTIGATOR · Emory University
Kimberly R Jacob Arriola, PhD, MPH
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Identifies as African American or Black
Two estimated glomerular filtration rates (eGFRs) \< 29 separated by at least 90 days but within the past 2 years, or a Kidney Failure Risk Equation (KFRE) score of 10% or greater likelihood of kidney failure within the next 2 years
Had an encounter at Emory Healthcare through an ambulatory visit or inpatient stay (i.e., ER or hospital visit within the previous 2 months
Stated willingness to comply with all study procedures and availability for the duration of the study

Exclusion

Currently on dialysis
currently receiving hospice care or other types of conservative management for terminal illness
Currently on waitlist, or referred for/or completed a transplant evaluation visit within the past 2 years
Kidney or another solid organ transplant
Active cancer treatment
Non-English speaking
Participating in another treatment or intervention study at the time of enrollment
Currently pregnant or planning to become pregnant at the time of recruitment
  • Time-to-Kidney Replacement Therapy w/Central Venous CatheterThroughout study participation up to 12 months

    Composite measure of time to transition to Kidney Replacement Therapy (KRT) using a central venous catheter (CVC) over the course of the study period

  • Time-to-deathThroughout study participation up to 12 months

    Composite measure of time to death over the course of the study period. A record of death in the electronic medical record (EMR), and the date of death will be recorded. If the data is not available in EMR, national death statistics will be checked, and the patient's family will be asked.